Smith & Nephew releases full-year report, appoints new CEO

On Tuesday, British medtech company Smith & Nephew, a competitor of Coloplast within wound care, has announced a CEO replacement in connection with the release of its full-year financial figures. The double news has been rewarded well on the London stock exchange, sending the company up by 2.1 percent to GBP 12.04.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Coloplast starts share buyback program
For subscribers
Coloplast upgrades growth expectations following acquisition
For subscribers